Emmaus Life Sciences, INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
OQB
Director Lim Seah H. of Emmaus Life Sciences, Inc. reports purchasing 20,000 shares of common stock at $0.04 per share on September 16, 2024.
OQB
Willis C. Lee, Co-President & COO of Emmaus Life Sciences, Inc., has increased his indirect holdings of common stock through purchases made via his Fidelity Roth IRA.